Disease Overview：Hyperprolactinemia（HPRL）
Hyperprolactinemia is a common endocrine disorder characterized by elevated serum prolactin levels, often leading to menstrual disturbances, galactorrhea, amenorrhea, infertility, and decreased libido in women—and erectile dysfunction or reduced testosterone in men. Etiologies include prolactin-secreting pituitary adenomas (prolactinomas), hypothalamic dysfunction, medications (e.g., antipsychotics, antidepressants), chronic renal failure, or idiopathic causes. Diagnosis relies on repeated fasting prolactin assays, MRI of the sella turcica to assess pituitary morphology, and exclusion of secondary contributors. First-line management involves dopamine agonists—cabergoline or bromocriptine—which normalize prolactin, shrink micro- and macroprolactinomas, and restore gonadal function in over 80% of patients. Surgical resection (transsphenoidal adenomectomy) or radiotherapy may be considered for drug-resistant or intolerant cases.
China offers distinct advantages for international patients seeking hyperprolactinemia care. Leading reproductive endocrinology centers—many affiliated with top-tier academic hospitals—combine deep expertise in pituitary disorders with advanced neuroimaging (3T MRI), intraoperative neuronavigation, and multidisciplinary fertility preservation protocols. Success rates for cabergoline-induced ovulation restoration exceed 90% in well-selected cases; surgical remission rates for microprolactinomas approach 95%. Treatment costs remain significantly lower than in the US, UK, or Germany—often 40–60% less—without compromising clinical rigor or regulatory compliance. As your dedicated medical tourism partner, we streamline access: coordinating consultations with certified reproductive endocrinologists, arranging MRI and hormonal testing, verifying hospital accreditation, providing itemized, transparent pricing, and offering end-to-end support—from visa assistance and accommodation to post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Hyperprolactinemia (Reproductive Medicine Department)
Non-Surgical / Medical Management
*Target Criteria:* Prolactin <200 ng/mL, microprolactinoma (<10 mm), idiopathic hyperprolactinemia, or fertility-seeking patients without mass effect.
- •First-line Dopamine Agonists
- *Cabergoline*: ¥180–¥360/month ($25–$50) — preferred for efficacy/tolerability
- •Baseline & Monitoring Labs
- Thyroid function (TSH, FT4): ¥120 ($17) - Renal/liver panel + CBC: ¥150 ($21)
- •Imaging (if indicated)
- •Fertility Support (if applicable)
Surgical / Interventional Options
*Eligibility Criteria:* Macroprolactinoma (>10 mm) with optic chiasm compression, drug intolerance/resistance, or rapid tumor growth despite ≥6 months of optimal medical therapy.
- •Transsphenoidal Endoscopic Surgery (TSS)
- Intraoperative MRI guidance (if used): +¥8,000 ($1,100)
- •Preoperative Workup
- Formal visual field testing (neuro-ophthalmology referral *only if chiasmal compression suspected*): ¥260 ($36) - Pre-anesthesia assessment + ECG + chest X-ray: ¥480 ($66)
Special/Complex Condition Management
- •Pregnancy in Hyperprolactinemia: Cabergoline discontinued upon conception; monthly prolactin + clinical monitoring: ¥240 ($33) per visit.
- •Renal Impairment or Elderly Patients: Titration-adjusted bromocriptine + quarterly renal function monitoring: +¥100 ($14) per lab panel.
- •Drug-Resistant Cases (PRL >500 ng/mL post-cabergoline): Referral to neuroendocrine tumor center for octreotide trial (off-label) — monthly cost: ¥4,500 ($620).
Quick Selection Guide
- •<35 years, fertility goal, PRL <100 ng/mL: Start cabergoline ($25/mo) + ovulation monitoring ($83/course) — *optimal first-line*.
- •Budget-constrained (<$100 total initial spend): Bromocriptine ($6/mo) + basic labs ($48) — requires stricter adherence.
- •Macroprolactinoma with headache/visual field defect: Immediate MRI ($250) → TSS ($3,850–$5,770) — *urgently indicated*.
- •Age >50 or comorbid CKD/heart failure: Bromocriptine low-dose + renal monitoring ($14/visit) — avoids cabergoline cardiac risk.
- •Post-surgery residual disease: Lifelong cabergoline ($25/mo) + annual MRI ($250) — standard surveillance.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hyperprolactinemia Medical Vacation Packages
Curated transparent all-inclusive packages combining Hyperprolactinemia treatment with China top medical destinations:
